Vetticaden Santosh
Insider CIK 1386932 · DEPO SVP, Chief Medical Officer *** · ANX Chief Medical Officer & SVP · INSY Interim CEO and CMO · CBST SVP & Chief Medical Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| DEPO DEPOMED INC | A Award deriv | 2018-02-06 | 2018-02-08 | 36,800 | — | $0 | 36,800 | SEC↗ |
| DEPO DEPOMED INC | A Award deriv | 2017-10-16 | 2017-10-18 | 109,343 | — | $0 | 109,343 | SEC↗ |
| DEPO DEPOMED INC | A Award deriv | 2017-10-16 | 2017-10-18 | 53,325 | — | $0 | 53,325 | SEC↗ |
| INSY Insys Therapeutics, Inc. | A Award deriv | 2017-02-21 | 2017-02-23 | 56,000 | — | $0 | 56,000 | SEC↗ |
| INSY Insys Therapeutics, Inc. | A Award deriv | 2017-02-21 | 2017-02-23 | 14,000 | — | $0 | 14,000 | SEC↗ |
| INSY Insys Therapeutics, Inc. | A Award deriv | 2017-01-12 | 2017-01-17 | 30,000 | — | $0 | 30,000 | SEC↗ |
| MSTX Mast Therapeutics, Inc. | A Award deriv | 2014-06-19 | 2014-06-20 | 529,300 | — | $0 | 529,300 | SEC↗ |
| MSTX Mast Therapeutics, Inc. | A Award deriv | 2014-01-02 | 2014-01-03 | 295,100 | — | $0 | 295,100 | SEC↗ |
| MSTX Mast Therapeutics, Inc. | A Award deriv | 2013-06-19 | 2013-06-21 | 125,000 | — | $0 | 125,000 | SEC↗ |
| ANX ADVENTRX PHARMACEUTICALS I | A Award deriv | 2012-09-05 | 2012-09-05 | 600,000 | — | $0 | 600,000 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | J Other | 2011-12-30 | 2012-01-04 | 340 | $30.80 | $10.5K | 8,773 | SEC↗ |